motherlodetv.net
Lexaria Bioscience Corp. (Nasdaq:LEXX) (Nasdaq:LEXXW) (CSE:LXX) (CNSX:LXX.CN) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce successful outcomes in its first sets of data from its 2021 applied research and development (R&D) study programs.
Lexaria Bioscience Corp. (Nasdaq:LEXX) (Nasdaq:LEXXW) (CSE:LXX) (CNSX:LXX.CN) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, today announced that CEO Chris Bunka is presenting at the Benzinga Global Small Cap Conference to be held on May 13-14, 2021. Complimentary investor registration can be accessed through the conference link below.
Tocvan Ventures Corp. (CSE:TOC) (“Tocvan” or the “Corporation”) is pleased to provide an update for its flagship Pilar Gold-Silver Project in Sonora, Mexico. The Phase II drill program (the “Program”) is nearing the half-way point with a total of 4,000 meters planned. To date, eleven (11) drill holes have been completed for a total of 1,811 meters (Figure 1). Samples for the first five holes have been submitted to ALS Labs in Hermosillo, the remaining samples will be submitted later this week. Early drilling focused on the extension of the Main Zone, testing deeper down-dip extensions of mineralization in addition to stepping out along strike. Drill targeting has now shifted towards testing new areas along the 4-Trench Extension and Triple Vein Zone areas.